Sign in
4

Changes in Ownership

Foghorn Therapeutics Inc. Filed Acc 0001828724-26-000003

Options or other derivatives

  • Chief Executive Officer acquired 1,075,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

GOTTSCHALK ADRIAN · Chief Executive Officer

Table II: Derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2026-02-05 Grant or award : show line 1 in the form Stock option (right to buy) +1,075,000 $5.23 $5,622,250 1,075,000 D
Loading xslF345X05/primarydocument.xml…